As decentralized clinical trials (DCTs) continue to grow at an unprecedented rate, personal support is emerging as a key component to improve protocol compliance, patient safety and study outcomes.
In this process, mobile nurses are crucial. A recent survey conducted by GlobalData in cooperation with PCM Trials (published at clinicaltrialsarena.com) shows that nurse home visits not only enhance patient retention but also reduce site burden and speed up enrollment—especially among elderly populations.
The clinical value of personal interaction
DCTs have introduced a multitude of new ways to engage patients, such as telemedicine, mobile health apps and wearable devices. But human interaction and personalized support cannot easily be replaced by digital means – and perhaps that shouldn’t even be a goal?
Data shows that nurse home visits not only provide a sense of safety and confidence, but actually improves the integrity of the clinical study too. According to the GlobalData survey, 91% of respondents agreed that mobile nurse visits improve patient retention. In short, mobile nurses are of massive importance when conducting off-site studies!
Mobile nurses save both time and money
Beyond improving the patient experience, using mobile nurses offers economic and logistical benefits for the research companies as well. In the survey, 76% of respondents cited reduced site burden as a key advantage, which can translate into significant cost savings for sponsors.
Faster recruitment is another major benefit — 91% of respondents believe mobile nurse visits expedite patient recruitment, which directly impacts trial timelines. Improved patient diversity (58%) was another perceived benefit of mobile home nurses.
Gaining the trust of elderly patients
For elderly patient populations, where recruitment has historically been challenging, mobile nurse visits have shown remarkable results. GlobalData’s analysis indicates that studies involving elderly participants and utilizing mobile visits had shorter enrollment periods by an average of 6.18 months and reduced overall trial duration by an average of 10.97 months compared to traditional trials. Again – massive numbers that in the end translate into huge savings.
To summarize: Mobile nurse visits are more than just a convenience—they are a strategic asset in decentralized clinical trials.
To summarize: Mobile nurse visits are more than just a convenience—they are a strategic asset in decentralized clinical trials.
As decentralized models become the norm, the combination of innovative technology and human-centric support will be key to unlocking the full potential of decentralized and hybrid trials.
Our global network of mobile nurses is ready to go!
Curious about how mobile nurses can transform your next hybrid trial? Let’s connect!
